Background: Heated humidified high-flow nasal cannula (HHHFNC) therapy has been widely used in preterm infants. However, evidence to support its use as a continuous positive airway pressure (CPAP) weaning method is still controversial. Objectives: We aimed to compare time to wean directly off CPAP vs. weaning by using HHHFNC. Methods: Infants with a gestational age (GA) of <32 weeks who met the predefined criteria for weaning off CPAP, i.e. with a CPAP of ≤6 cm H2O and a fraction of inspired oxygen (FiO2) of ≤0.3 for at least 24 h, were randomly assigned to wean by using HHHFNC or wean directly from CPAP. In the HHHFNC group, flow rate was reduced by 1 liter/min every 24 h to 2-3 liters/min depending on body weight (i.e. < or ≥1,000 g), and then HHHFNC was discontinued. In the CPAP group, pressure was reduced by 1 cm H2O every 24 h until stable on CPAP 4 cm H2O and then discontinued. The primary outcome was the time it took to wean off the use of the CPAP or HHHFNC devices. Results: One-hundred and one infants were enrolled, 51 in the HHHFNC and 50 in the CPAP group. Both groups had similar demographics and respiratory conditions before enrollment. There was no difference in time to successfully wean between the 2 groups [median (IQR): 11 (4-21) days in the HHHFNC group vs. 11 (4-29) days in the CPAP group; p = 0.12]. There were no differences in morbidities or related complications. Infants in the HHHFNC group had significantly less nasal trauma (20 vs. 42%; p = 0.01). Conclusions: In our study, the time to wean off CPAP using HHHFNC was not different from when weaning directly from CPAP.

Keywords:
High-flow nasal cannula, Weaning, Continuous positive airway pressure
1.
Diblasi RM: Nasal continuous positive airway pressure (CPAP) for the respiratory care of the newborn infant. Respir Care 2009;54:1209-1235.
2.
Manley BJ, Dold SK, Davis PG, Roehr CC: High-flow nasal cannulae for respiratory support of preterm infants: a review of the evidence. Neonatology 2012;102:300-308.
3.
Wilkinson D, Andersen C, O'Donnell CP, De Paoli AG: High flow nasal cannula for respiratory support in preterm infants. Cochrane Database Syst Rev 2011:CD006405.
4.
Hough JL, Shearman AD, Jardine LA, Davies MW: Humidified high flow nasal cannulae: current practice in Australasian nurseries, a survey. J Paediatr Child Health 2012;48:106-113.
5.
Nath P, Ponnusamy V, Willis K, Bissett L, Clarke P: Current practices of high and low flow oxygen therapy and humidification in UK neonatal units. Pediatr Int 2010;52:893-894.
6.
Manley BJ, Owen LS, Doyle LW, Andersen CC, Cartwright DW, Pritchard MA, et al: High-flow nasal cannulae in very preterm infants after extubation. N Engl J Med 2013;369:1425-1433.
7.
Collins CL, Holberton JR, Barfield C, Davis PG: A randomized controlled trial to compare heated humidified high-flow nasal cannulae with nasal continuous positive airway pressure postextubation in premature infants. J Pediatr 2013;162:949-954 e1.
8.
Yoder BA, Stoddard RA, Li M, King J, Dirnberger DR, Abbasi S: Heated, humidified high-flow nasal cannula versus nasal CPAP for respiratory support in neonates. Pediatrics 2013;131:e1482-e1490.
9.
Abdel-Hady H, Shouman B, Aly H: Early weaning from CPAP to high flow nasal cannula in preterm infants is associated with prolonged oxygen requirement: a randomized controlled trial. Early Hum Dev 2011;87:205-208.
10.
Sasi A, Malhotra A: High flow nasal cannula for continuous positive airway pressure weaning in preterm neonates: a single-centre experience. J Paediatr Child Health 2015;51:199-203.
11.
Sreenan C, Lemke RP, Hudson-Mason A, Osiovich H: High-flow nasal cannulae in the management of apnea of prematurity: a comparison with conventional nasal continuous positive airway pressure. Pediatrics 2001;107:1081-1083.
12.
Kugelman A, Riskin A, Said W, Shoris I, Mor F, Bader D: A randomized pilot study comparing heated humidified high-flow nasal cannulae with NIPPV for RDS. Pediatr Pulmonol 2015;50:576-583.
13.
Bowe L, Clarke P: Current use of nasal continuous positive airways pressure in neonates. Arch Dis Child Fetal Neonatal Ed 2005;90: F92-F93.
14.
Fernandez-Alvarez JR, Gandhi RS, Amess P, Mahoney L, Watkins R, Rabe H: Heated humidified high-flow nasal cannula versus low-flow nasal cannula as weaning mode from nasal CPAP in infants ≤28 weeks of gestation. Eur J Pediatr 2014;173:93-98.
15.
Amatya S, Rastogi D, Bhutada A, Rastogi S: Weaning of nasal CPAP in preterm infants: who, when and how? A systematic review of the literature. World J Pediatr 2015;11:7-13.
16.
Rastogi S, Wong W, Gupta A, Bhutada A, Deepa R, Maimonides Neonatal G: Gradual versus sudden weaning from nasal CPAP in preterm infants: a pilot randomized controlled trial. Respir Care 2013;58:511-516.
17.
Todd DA, Wright A, Broom M, Chauhan M, Meskell S, Cameron C, et al: Methods of weaning preterm babies <30 weeks gestation off CPAP: a multicentre randomised controlled trial. Arch Dis Child Fetal Neonatal Ed 2012;97:F236-F240.
18.
Badiee Z, Eshghi A, Mohammadizadeh M: High flow nasal cannula as a method for rapid weaning from nasal continuous positive airway pressure. Int J Prev Med 2015;6:33.
19.
Wilkinson DJ, Andersen CC, Smith K, Holberton J: Pharyngeal pressure with high-flow nasal cannulae in premature infants. J Perinatol 2008;28:42-47.
20.
Jobe AH, Bancalari E: Bronchopulmonary dysplasia. Am J Respir Crit Care Med 2001;163:1723-1729.
21.
Say B, Kanmaz Kutman HG, Oguz SS, Oncel MY, Arayici S, Canpolat FE, et al: Binasal prong versus nasal mask for applying CPAP to preterm infants: a randomized controlled trial. Neonatology 2016;109:258-264.
22.
Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM: Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med 2003;349:959-967.
23.
Kotecha SJ, Adappa R, Gupta N, Watkins WJ, Kotecha S, Chakraborty M: Safety and efficacy of high-flow nasal cannula therapy in preterm infants: a meta-analysis. Pediatrics 2015;136:542-553.
24.
Dysart K, Miller TL, Wolfson MR, Shaffer TH: Research in high flow therapy: mechanisms of action. Respir Med 2009;103:1400-1405.
© 2016 S. Karger AG, Basel
2016
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.